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Brief Definit ive Report
DNA double strand breaks (DSBs) pose a se-
vere threat to genome integrity, but can also be 
a necessary part of normal cellular processes, 
such as meiosis and Ig class switch recombina-
tion (CSR). Depending on cell cycle phase and 
DSB structure, different strategies are used for 
repair. Homologous recombination (HR) de-
pends on a homologous DNA template for repair, 
preferentially the identical sister chromatid, and 
is therefore mainly active during the S and G2 
phases. Nonhomologous end joining (NHEJ), 
however, is active throughout the cell cycle and 
is the principal pathway during the G1 phase, 
when there is no immediate close template for 
homologous repair. The classical NHEJ path-
way requires not only the key components of 
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DNA double strand breaks (DSBs) are mainly repaired via homologous recombination (HR) 
or nonhomologous end joining (NHEJ). These breaks pose severe threats to genome integ-
rity but can also be necessary intermediates of normal cellular processes such as immuno-
globulin class switch recombination (CSR). During CSR, DSBs are produced in the G1 phase 
of the cell cycle and are repaired by the classical NHEJ machinery. By studying B lympho-
cytes derived from patients with Cornelia de Lange Syndrome, we observed a strong corre-
lation between heterozygous loss-of-function mutations in the gene encoding the cohesin 
loading protein NIPBL and a shift toward the use of an alternative, microhomology-based 
end joining during CSR. Furthermore, the early recruitment of 53BP1 to DSBs was reduced 
in the NIPBL-deficient patient cells. Association of NIPBL deficiency and impaired NHEJ 
was also observed in a plasmid-based end-joining assay and a yeast model system. Our 
results suggest that NIPBL plays an important and evolutionarily conserved role in NHEJ, in 
addition to its canonical function in sister chromatid cohesion and its recently suggested 
function in HR.
© 2013 Enervald et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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in NIPBL, SMC1A, SMC3 (Schoumans et al., 2007), MAU2, 
or PDS5B (Fig. 1 A and Table 1).  For comparison, LCLs or 
FBs from healthy individuals, radiation-sensitive patients (ATM- 
or Cernunnos-deficient), and a Roberts syndrome (RBS) pa-
tient were also evaluated. RBS is caused by mutations in the 
gene encoding ESCO2, which is responsible for establishment 
of cohesion.
LCLs from patients (P1-P5) and controls (LCL1-LCL3) 
were exposed to increasing dosages of -irradiation (-IR). After 
the time required for three population doublings in the absence 
of DNA damage, the relative number of viable cells was deter-
mined using a MTS proliferation assay. Low doses of -IR caused 
a significantly reduced survival in all CdLS LCLs tested, com-
pared with controls (Fig. 1 B and Table 1). The radiation sensitiv-
ity was confirmed by a colony formation assay in FBs from P7 
and P10 after exposure to -IR (Fig. 1 C). We also treated the 
control FBs with NIPBL siRNA. This typically resulted in >70% 
reduction of the NIPBL protein levels (Fig. 1 E) and caused 
a significant increase in sensitivity to -IR as analyzed by the 
colony formation assay (Fig. 1 D). The general DNA damage 
response, however, can be activated properly in NIPBL knock-
down cells, as measured by the level of phosphorylated ATM and 
Chk2 (Fig. 1 F). The P1-P5 cells were also found to be sensitive 
to the interstrand cross-linking agent mitomycin C and the 
topoisomerase II inhibitor etoposide to various degrees (unpub-
lished data). Collectively, there was an increased DNA damage 
sensitivity in CdLS cells, especially to agents inducing DSBs.
Proper S-phase cohesion has been shown to be essential 
for HR-mediated repair of DSBs during G2 in yeast (Sjögren 
and Nasmyth, 2001). One explanation for the DNA damage 
sensitivity in cells from NIPBL-deficient CdLS patients could 
be defective S-phase established cohesion caused by insuffi-
cient cohesin loading. Although precocious sister chromatid 
separation (PSCS) has been shown in CdLS cells in one study 
(Kaur et al., 2005), metaphase spreads of the CdLS cell lines 
included in this study did not, in line with other studies (Vrouwe 
et al., 2007; Liu and Baynam, 2010), show any increased PSCS 
(unpublished data). Thus, the increased DNA damage sensi-
tivity in CdLS cells is probably independent of the canonical 
role of the cohesin complex in cohesion.
DSB repair via NHEJ is impaired in NIPBL-deficient cells
When determining the cell cycle distribution, we found that the 
majority (62–88%) of control and NIPBL-deficient CdLS patient 
cells were in the G1 phase of the cell cycle at the time of -IR 
exposure (unpublished data). This raised the possibility that NIPBL 
may not only be important for HR, but also for NHEJ, as the lat-
ter is the predominant pathway used for repair of DSBs during 
G1. To further understand how DSB end joining is performed in 
CdLS cells and to investigate whether NIPBL is important for 
NHEJ, we used three experimental systems outlined below.
Altered pattern of switch recombination  
junctions in NIPBL-deficient B cells
CSR is a physiological process that is initiated by a B cell–
specific factor, activation-induced cytidine deaminase (AID), 
the NHEJ machinery, i.e., Ku70/Ku80, DNA-PKcs, Artemis, 
XLF (Cernunnos), XRCC4, and DNA ligase IV, but also several 
DNA damage sensors or adaptors, such as ATM, H2AX, 53BP1, 
MDC1, RNF168, and the Mre11–Rad50–NBS1 complex.
Cohesin is an evolutionarily conserved multisubunit com-
plex consisting of a heterodimer of two structural maintenance 
of chromosomes (SMC) proteins, SMC1A and SMC3, one 
kleisin protein RAD21 (MCD1 or SCC1) and SA (STAG1/2 
or SCC3). The SMC proteins fold back on themselves in the 
hinge region to form long antiparallel coiled-coil arms, with 
the amino and carboxyl termini coming together to create 
head domains that contain ATPases. RAD21 bridges the two 
head domains to facilitate the formation of the proposed ring-
like structure of the complex, and it also interacts with the SA 
subunit. The cohesin complex ensures correct chromosome seg-
regation through cohesion between sister chromatids (Nasmyth 
and Haering, 2009). In addition to this canonical role, cohesin 
and its loading complex NIPBL/MAU2 have also been sug-
gested to be important for regulation of gene expression and 
repair of DSBs through HR, presumably by facilitating prox-
imity between the broken DNA ends and the repair template 
(Sjögren and Nasmyth, 2001; Vrouwe et al., 2007; Nasmyth 
and Haering, 2009). Smc1, the yeast SMC1A orthologue, has 
furthermore been suggested to coordinate the HR and NHEJ 
processes (Schär et al., 2004).
Cornelia de Lange syndrome (CdLS) is a developmental 
disorder characterized by growth retardation, severe intellec-
tual disability, gastrointestinal abnormalities, malformations, of 
the upper limbs and characteristic facial dysmorphisms. Het-
erozygous loss-of-function mutations in NIPBL, encoding 
the cohesin loader NIPBL, are the major cause of CdLS (Liu 
and Baynam, 2010). In addition, mutations in the SMC1A, 
SMC3, PDS5B, RAD21, and HDAC8 encoding genes, all 
being part of the cohesion pathway, have been found in se-
lected CdLS patients. The multisystem dysfunctions con-
nected to the syndrome implicate defective gene regulation 
during fetal development and current evidence suggests that 
CdLS may be caused by alterations in cohesin chromatin-
binding dynamics (Liu et al., 2009). In addition, cell lines es-
tablished from CdLS patients have an increased sensitivity to 
DNA damage that has been suggested to be caused by defec-
tive HR-mediated repair (Vrouwe et al., 2007).
Here, we show an increased DNA damage sensitivity, espe-
cially after exposure to -rays, in B-lymphoblastoid (LCLs) and 
fibroblast cell lines (FBs) from NIPBL-deficient CdLS patients. 
However, we also observed that the majority of the patient and 
control cells studied were in the G1 phase of the cell cycle, where 
NHEJ is the principle DSB repair mechanism. We therefore 
investigated whether defective NHEJ could underlie the DNA 
damage sensitivity observed in the patient cells.
RESULTS AND DISCUSSION
Increased DNA damage sensitivity in CdLS cell lines
DNA damage sensitivity assays were performed using LCLs 
and FBs from 7 CdLS patients (P1-P3, P5, P7, P10 had defined 
NIPBL mutations, whereas P4 had no coding region mutation 
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7 CdLS patients with NIPBL mutations (P1, P2, P3, P6, 
P8, P9, and P10, 1–17 yr old) and 6 age-matched controls 
(1–13 yr old) and compared them to those previously de-
scribed in DNA ligase IV, Artemis, and ATM-deficient patients 
(Pan-Hammarström et al., 2005; Du et al., 2008). Altogether, 
92 unique CSR junctions (91 S–S and 1 S–S–S) from 
NIPBL-deficient patient B cells, representing independent 
CSR events, were PCR amplified and sequenced. 46 unique 
CSR junctions were also obtained from the controls, and this 
set of data was merged with our previously described data 
from control children (1–6 yr; 137 junctions; Du et al., 2008) 
as the two sets of controls were largely similar. As one CdLS 
patient with NIPBL mutation (P3) was 17 yr old at the time 
through DNA deamination, but relies on ubiquitously ex-
pressed DNA repair factors for subsequent DSB formation 
(mismatch and base excision repair factors) and joining of the 
broken DNA ends (NHEJ factors; Stavnezer et al., 2010). 
During CSR, DSBs are generated in the donor and acceptor 
switch (S) regions. These breaks are processed and repaired 
during the G1 phase of cell cycle, leading to recombination 
of the two S regions (Sharbeen et al., 2012). The nature of 
the recombination junctions reflect the DNA repair path-
way used, and defects in the NHEJ machinery have pre-
viously been associated with characteristic abnormalities 
(Pan-Hammarström et al., 2005; Yan et al., 2007). We therefore 
sequenced CSR junctions from in vivo–switched B cells from 
Figure 1. NIPBL-deficient cells display 
increased DNA damage sensitivity.  
(A) Schematic representation of NIPBL (not to 
scale) with approximate localization of con-
served motifs, and relative positioning of 
mutations identified in the CdLS patients 
included in this study. (B) LCLs from healthy 
controls and CdLS patients (P1-P3 and P5 had 
defined NIPBL mutations), as well as LCLs 
from patients deficient for ESCO2 (RBS) or 
ATM (AT) were exposed to -IR at indicated 
dosages, and survival was monitored after 
three population doublings using the MTS 
assay. Doubling times and significant differ-
ences in survival are indicated in Table 1. 
(C) FBs from patients deficient in NIPBL  
(P7 and P10), Cernunnos, or control FBs were 
exposed to -IR at indicated dosages and 
analyzed for survival by the colony formation 
assay. (D) Control FBs were transfected with 
control (siCTRL) or NIPBL siRNA (siNIPBL) and 
exposed to -IR at indicated dosages and 
analyzed for survival by the colony formation 
assay. (B–D) An average from ≥3 experiments 
for each cell type is shown, and error bars 
indicate SD. (E) Protein extracts were isolated 
from control FBs 48 h after transfection with 
siCTRL or siNIPBL, but before exposure to -IR 
for the colony formation assay shown in D, 
and were run on SDS gels. (F) Control FBs 
were transfected with siCTRL or siNIPBL, and 
48 h after transfection and at indicated time 
points after exposure to -IR, protein extracts 
were isolated and run on SDS gels.  
(E and F) Indicated proteins were detected by 
Western blotting. Representative gels from 
three independent experiments are shown.
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We also observed an unusual sequence of an amplified 
S-S fragment in NIPBL-deficient patient’s cells, with two 
large pieces of S4 regions inserted between the S and S 
regions, one of which is inverted (S-S4-S4rev-S2). This 
type of junction, with inverted S regions inserted at the 
breakpoints, has not been observed in any of the CSR junc-
tions derived from control B cells.
We furthermore characterized 51 S-S junctions from 
4 CdLS patients with X-linked SMC1A mutations (S1-S4). 
These junctions showed a similar trend, albeit less dramatic, in 
shifting to MH-based end joining (Fig. 2, B and C).
Descriptions of the immunological phenotype of CdLS 
patients are scarce in the literature. No overt clinical manifes-
tations of immunodeficiency, characterized by recurrent, se-
vere, or unusual infections, were observed in any of the CdLS 
patients included in the study. The total Ig levels were largely 
normal in three patients where serum samples were avail-
able (P8, P9 and P10), although two patients (P8 and P9) had 
reduced or borderline low level of specific antibodies (IgG 
isotype) against Haemophilus influenzae, which may indicate a 
subtle defect in CSR. We subsequently reviewed three addi-
tional CdLS patients with defined NIPBL mutations from 
whom cryopreserved peripheral blood cells were available. 
Two patients (P12 and P13) showed a reduced or borderline 
of sampling, and we have previously shown that there are 
some differences in the CSR pattern between adult and child 
controls, we also included our previously described adult con-
trols (Du et al., 2008) for comparison (Fig. 2, B and C). There 
was a significantly reduced proportion of S-S junctions 
in NIPBL-deficient B cells with direct end joining, i.e., no 
microhomology (MH; perfectly matched, short donor–acceptor 
sequence homology) and no insertions (nontemplate nucleo-
tide additions) at the junctions (Fig. 2, B and C). The number 
of junctions with 1-bp insertions was also significantly re-
duced (Fig. 2, B and C). Conversely, a significantly increased 
proportion of the S-S junctions from NIPBL-deficient 
patient B cells displayed MH of at least 1 bp (89 vs. 60 or 
57% in children or adult control group, respectively; 2 test; 
P < 0.001). The mean length of MH was dramatically in-
creased in NIPBL-deficient patients (7.0 ± 5.1 bp) as com-
pared with 3.9 ± 4.9 bp in children controls and 1.8 ± 3.2 bp 
in adult controls (Student’s t test, P = 4.7 × 106 or P = 8 × 
1015). The pattern of in vivo–generated CSR junctions 
from NIPBL-deficient patients thus largely resembles that 
observed in patients with NHEJ defects (DNA ligase IV or 
Artemis deficiency) or ATM deficiency, which are character-
ized by a lack of “direct end joining” and a shift toward MH 
usage (Fig. 2, B and C).
Table 1. Patient and mutation information
Age (years) NIPBL mutationa Doubling timeb NIPBL RNA/Protein  
% of control
-IRc Increased 
microhomology
P1 3 c.2494C>T; p.Arg832X 46 h 75/50 1 Gy****  
3 Gy****  
9 Gy***
YES
P2 13 c.4320+2T>A; p.Val1441_Lys1520del 75 h 60/50 1 Gy****  
3 Gy***  
9 Gy**
YES
P3 17 c.6250_6255del; p.Val2084_Val2085del 44 h 90/60 1 Gy**  
3 Gy*  
9 Gy n.s.
YES
P4 14 ND 50 h 60/50 1 Gy****  
3 Gy****  
9 Gy n.s.
NA
P5 13 c.7306G>A; p.Ala2436Thr 42 h 150/70 1 Gy*  
3 Gy***  
9 Gy n.s.
NA
P6 2 c.4593T>A; p.Tyr1531X 42 h NA NA YES
P7 1 c.6436A>C; p.Thr2146Pro NA NA/50 1 Gy*  
3 Gy*  
9 Gy n.s.
YES  
Plasmid
P8 4 c.4321G>T; p.Val1441Leu NA NA NA YES
P9 1 c.4320+5G>C; p.Val1414_Ala1440del NA NA NA YES
P10 10 c.6242G>C; p.Gly2081Ala NA NA/40 1 Gy*  
3 Gy n.s.  
9 Gy n.s.
YES  
Plasmid
aAll mutations described are de novo. ND, not detected.
bDoubling times for control cell lines (LCL1-3) were between 23 to 32 h. NA, not analyzed.
cStatistical comparison of -IR sensitivity was performed between P1-P5 and LCL2 and between P7 and P10 and control FB, *, P < 0.05, **, P < 0.01, ***, P < 0.005,  
****, P < 0.001 (Student’s t test). n.s., not significant.
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Figure 2. Increased usage of microhomologies at S–S junctions in NIPBL-deficient cells. (A) S and S recombination junctions from patient and control 
B cells were amplified via nested PCR and sequenced. Four sequences of recombination junctions from NIPBL-deficient patients are shown, representing different 
types of joining, including direct joining, 1-bp insertion, and microhomology (MH)-based joining. The S and S reference sequences are aligned above and below the 
recombination junction sequences. MHs and imperfect repeats are indicated by boxes (solid and dotted lines, respectively). OL, overlap. The S and S breakpoints for 
each switch fragment are indicated by black arrowheads, and their positions in the reference sequences are indicated above or below the arrowheads. (B) The accumu-
lated percentages of switch junctions with given lengths of MH are plotted. (C) The age-matched control data (1–13 yr; 44 junctions) derived from the present study 
were merged with the previously published children control data (1–6 yr; 137 junctions; Du et al., 2008). The CSR junctions from the adult controls were described 
previously (Du et al., 2008). Significant differences (as compared with both children and adult control groups) are highlighted with bold letters and indicated by arrows 
(2 test, P < 0.05). (A–C) DNA from each patient was tested in 10 separate PCR reactions for each experiment, and the experiment was repeated at least once.
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was significantly increased in Cernunnos- and NIPBL-deficient 
cells when compared with the controls (Table 2). A similar 
trend was observed in Artemis-deficient cells, although not to 
a significant level, which is consistent with a previous study 
using a similar construct (Noordzij et al., 2003). Deletions 
(nucleotide loss at the DNA ends), caused by resection of the 
DNA ends, could also be detected in 10–30% of recombi-
nation junctions in cells from controls and different groups of 
patients. Notably, there was a significant increase of junc-
tions with deletions, especially deletions that are associated 
with short MH (typically 1–4 bp) in NIPBL-deficient cells 
(Table 2), suggesting that an alternative end joining pathway, 
involving DNA end resection and short sequence homolo-
gies is more active when the function of NIPBL is impaired. 
The plasmid-based assay was subsequently performed in G1-
arrested FB cells from P7, and a similar end-joining defect 
was observed (Table 2).
To further investigate if the end-joining defect observed 
in the patient cell lines in this assay was specifically associated 
with NIPBL deficiency, we transfected the control FBs with 
siRNA against NIPBL 2 d before the transfection of linear-
ized plasmids. As measured by quantitative real-time PCR 
assay, the expression of NIPBL was reduced by 20% and 65%, 
respectively after the treatment of scrambled control (siCTRL) 
or specific NIPBL siRNA (siNIPBL). As demonstrated in 
Table 2, the NIPBL knockdown cells showed a very similar 
end-joining pattern to that derived from the NIPBL-deficient 
patient cells, with significantly reduced direct joining and 
increased usage of 6-bp MH as well as deletions associated 
with short MH. Collectively, NIPBL deficiency appears to 
percentage of class-switched CD19+CD27+IgMIgD mem-
ory B cells. Moreover, B cells from P11 and P12 showed a 
normal cell proliferation rate but a reduced ability to switch 
to IgE in response to cytokines in an in vitro CSR assay (unpub-
lished data).
Collectively, deficiency of the cohesin loader NIBPL re-
sults in a moderately reduced efficiency of CSR but, more 
importantly, an abnormal pattern of recombination junctions. 
The skewing toward the MH-based alternative end joining 
(A-EJ) pathway implicates that the classical NHEJ is compro-
mised in NIPBL-deficient cells.
Increased MH-based joining of blunt ends in NIPBL-
deficient cells in an in vitro plasmid–based assay
We next used a previously described assay where linearized 
plasmids with defined blunt DNA ends were transiently 
transfected into FBs (Verkaik et al., 2002). The contribution 
of direct joining, where two blunt DNA ends are joined pre-
cisely, and 6-bp MH-based end joining can be estimated by 
restriction enzyme digestion or, more accurately, determined 
by direct sequencing. FBs from patients with deficiency of 
NIPBL (P7, P10) or Artemis and one unaffected individual 
were studied by this assay, and previously published data from 
Cernunnos-deficient cells were included for comparison 
(Du et al., 2012). As shown in Table 2, the proportion of direct 
joining was dramatically reduced in Cernunnos-deficient 
cells (4.4 vs. 73.0% in controls) and to a lesser, but significant 
degree, in NIPBL-deficient cells (45.8%, 2 test; P = 6.106). 
Conversely, the proportion of 6-bp, MH-mediated end joining 
Table 2. Reduced direct joining and increased use of microhomology in a plasmid-based end-joining assay  
in NIPBL-deficient cellsa
Direct joining 6-bp MH Deletion + MH Deletion only Insertion Total no. of 
junctions
% % % % %
Controlb 73.0 6.3 7.9 11.9 0.8 126
Artemis/  
p with control
59.5  
0.099
11.9  
0.243
14.3  
0.225
11.9  
1.000
2.4  
0.411
42
Cernunnos/  
p with control
4.4  
7.5 × 1020
80.9  
3.8 × 1026
14.7  
0.139
0  
3.1 × 103
0  
0.461
68
NIPBL+/(P7+P10)  
p with control
45.8  
6.1 × 106
20.8  
6.4 × 104
22.9  
7.9 × 104
10.4  
0.698
0  
0.284
144
NIPBL+/ (P7), G1 arrested  
p with control
43.1  
1.7 × 104
27.5  
1.2 x104
21.6  
0.011
7.8  
0.429
0  
0.523
51
Control+ siCTRL  
p with control
68.6  
0.509
8.6  
0.563
10.0  
0.623
12.9  
0.846
0  
0.455
70
Control + siNIPBL  
p with control  
p with siCTRL
52.1  
0.003  
0.044
16.4  
0.022  
0.156
19.2  
0.019  
0.121
12.3  
0.930  
0.924
0  
0.445
73
aLinearized pDVG94 plasmid was transfected into FBs derived from NIPBL, Artemis and Cernunnos deficient patients and one control. At least two independent experiments 
are summarized.
bPart of the control data (n = 106) as well as the junctions derived from Cernunnos deficient cells have been described previously (Du et al., 2012). The two sets of controls 
showed very similar pattern and were thus merged in the summary. Statistical analysis was performed using 2 test.
JEM Vol. 210, No. 12 2509
Br ief Definit ive Repor t
the cells are arrested in G1, there are some cells that still pro-
ceed into G2. Furthermore, occasionally (not measurable by 
pulse field gel electrophoresis), there might be a few cells with 
breaks only on one chromatid, and if these cells by chance enter 
into the G2 phase, they can theoretically still be repaired by 
HR. Thus, the slightly more severe defect observed in scc2-4 
cells compared with the lig4 cells could be due to the fact that 
Scc2 is also required for HR, whereas DNA ligase IV only has 
a function in NHEJ.
To further investigate the type of repair used in the sur-
viving cells, a 600-bp region encompassing the HO cut site 
was amplified and subsequently sequenced in cells derived from 
single colonies. In the surviving WT cells, the HO-induced 
DSBs were, indeed, repaired by NHEJ with most of the re-
covered junctions having small deletions and insertions, as 
previously described (Moore and Haber, 1996; Fig. S1). How-
ever, most of the amplified sequences derived from the few 
colonies of surviving Scc2 or DNA ligase IV–inactivated cells 
are germline at the MAT locus (Fig. S1), suggesting that 
these surviving cells are probably those few cells that had no 
DSB induced at this locus. Altogether, our data clearly points 
to a role for NIPBL orthologues in the classical NHEJ.
Potential mechanisms for the involvement of NIPBL in NHEJ
By sequencing of Ig S-S recombination joints, through 
analysis of DSB rejoining in a plasmid assay, and by a NHEJ 
assay in yeast, we demonstrated that NIPBL is important for 
result in a reduced direct joining of blunt ends but an increased 
MH-based joining of resected DNA ends, in the G1 phase of 
the cell cycle in this plasmid-based assay.
Involvement in NHEJ is a conserved function of NIPBL
Lastly, we analyzed the importance of NIPBL for NHEJ using 
genetically modified Saccharomyces cerevisiae strains. The yeast 
NIPBL orthologue Scc2 is an essential protein, required for cell 
survival (Michaelis et al., 1997), thus we used a temperature-
sensitive allele of SCC2 (scc2-4). Logarithmically growing wild-
type, scc2-4, lig4, or scc2-4 lig4 cells were arrested in G1 by 
addition of the A-factor pheromone (O’Reilly et al., 2012; 
Fig. 3 A). The temperature was then raised to the restrictive 
level for 30 min and the galactose-inducible HO endonuclease 
was activated by addition of galactose to create a sequence-
specific DSB at the yeast MAT locus (Fig. 3 B). This DSB 
could be repaired solely via NHEJ, as the intrachromosomal 
regions normally used for its repair via HR were deleted and 
the DSB was induced on both sister chromatids (Moore and 
Haber, 1996). After 1 h of break induction, the cells were plated 
in serial dilutions for analysis of survival. This showed that 
Scc2 might be as important for NHEJ as DNA ligase IV (lig4), 
a defined, conserved and essential NHEJ factor (Fig. 3 B). 
It is notable that scc2-4 alone and in combination with lig4 
resulted in a slightly more severe defect than the lig4 alone, 
which could reflect that Scc2 has additional functions for DSB 
repair than DNA ligase IV. It is possible that although most of 
Figure 3. The involvement of NIPBL in 
NHEJ is evolutionarily conserved.  
(A and B) WT cells, cells expressing a tempera-
ture-sensitive allele of the yeast NIPBL ortho-
logue SCC2 (scc2-4), and cells with a deletion 
of lig4, either alone or in combination with 
the scc2-4, were arrested in G1 by addition of 
A-factor for 2 h and subsequently incubated 
at a restrictive temperature (32°C) for 30 min. 
A site-specific DSB was then induced by the 
galactose inducible HO enzyme for 60 min, as 
indicated, during continuous G1 arrest at a 
restrictive temperature. (A) The cell cycle dis-
tribution was determined by FACS analysis 
before addition of A-factor and on G1- 
arrested cells, 2 h after addition of A-factor. 
(B) After DSB induction, cells were plated in 
the absence of galactose at equal starting 
concentrations and in 6 10-fold subsequent 
dilution steps (indicated by triangle). Plates 
were left to recover for 72 h at 30°C (semiper-
missive temperature for scc2-4). One repre-
sentative experiment from ≥3 is shown.
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where recruitment of 53BP1 to DSBs is reduced, a dramatically 
increased usage of MH was also observed at the S-S junc-
tions (Stewart et al., 2007). Thus, NIPBL may regulate NHEJ 
by recruiting 53BP1 to the DSB sites, but it is likely that in-
teractions between NIPBL and the DNA damage response 
factors are complex and that factors in addition to 53PB1 
may also influence the function of NIPBL in NHEJ.
Given that cohesin and NIPBL have been shown to regu-
late gene expression, an indirect effect caused by dysregula-
tion of genes involved in the respective DSB repair pathway 
cannot be ruled out. We have thus performed real-time PCR 
assays on nonirradiated and -ray–irradiated NIPBL knock-
down fibroblasts, but no significant changes in the expression 
of NHEJ genes (LIG4/DNA ligase IV, PRKDC/DNA-PKcs, 
and XRCC5/KU80) were observed (unpublished data). Fur-
thermore, the expression at the protein level of another key 
NHEJ factor XRCC4 was not significantly affected in the 
NIPBL knockdown cells (Fig. 1 F). Cohesin has also been 
shown to co-localize with the CCCTC-binding factor (CTCF), 
both genome wide and in the Ig locus, and these interac-
tions have been suggested to be important for CTCF insula-
tor function and three-dimensional chromosomal interactions 
(Degner et al., 2011). Moreover, it was recently shown that 
cohesin influences the rearrangement of the T cell receptor 
 locus through histone methylation, recruitment of the Rag 
repair of DSBs via the classical NHEJ pathway. NIPBL may, 
however, not be a component of the classical NHEJ machin-
ery as such, which includes DNA-PKcs, Ku70/80, Cernunnos, 
Artemis, DNA ligase IV, and XRCC4, as deficiency of any of 
these factors will result in a more pronounced immunodefi-
ciency syndrome due to a severe V(D)J recombination defect, 
another physiological process in lymphocytes that requires 
the classical NHEJ pathway (de Villartay, 2009). The CdLS 
patients with NIPBL mutations described here have no overt 
V(D)J recombination defect (unpublished data) but rather a 
CSR defect, which is more similar to patients with ATM- or 
NBS- deficiency as well as the 53BP1-, H2AX-, and MDC1- 
deficient mouse models (Stavnezer et al., 2010). Based on the 
current experimental evidence, partial loss of NIPBL is more 
likely to affect the regulation of the classical NHEJ pathway, 
or for the choice between the classical NHEJ and A-EJ.
To date, no cohesin-independent function has been de-
scribed for NIPBL. Thus, several mechanisms for the involve-
ment of NIPBL in NHEJ, probably dependent on cohesin, 
can be proposed. RNAi-mediated inactivation of the cohesin 
component Rad21/SCC1 has been shown to result in defects 
in recruitment of the DNA damage response factor and me-
diator protein 53BP1 to DSBs (Watrin and Peters, 2009). In-
triguingly, absence of 53BP1 has previously been shown to lead 
to increased resection around a DSB in the Ig S regions and a 
short-range repair via the MH-based A-EJ was consequently 
favored (Bothmer et al., 2010). As CdLS patients with deficient 
NIPBL have reduced levels of chromatin-bound cohesin (Liu 
et al., 2009), it is possible that 53BP1 recruitment is also re-
duced in patient cells and thus results in an increased rate of 
resection of DNA ends and higher degree of DSB repair via 
MH-mediated A-EJ. To test this hypothesis, we analyzed the 
53BP1 foci formation in response to DSB in NIPBL-deficient 
LCLs. Control LCLs and cells from P1-P3 and P5 were ex-
posed to -IR (1 Gy) and stained for 53BP1 at indicated time 
points (Fig. 4). In undamaged cells, the numbers of foci were 
low, with no apparent difference between control and patient 
cells. There was however a significant difference (Mann-Whitney 
U test, P = 6.85 × 108) in the number of foci formed 30 min 
after IR, between control LCLs and patient cells (Fig. 4). 
At a later time point (90 min), no significant difference was 
observed (Fig. 4). Thus, with an impaired function of NIPBL, 
the early recruitment of 53BP1 to DNA damage repair foci 
in response to DSBs was indeed reduced.
There is currently no patient with 53BP1 deficiency de-
scribed; however, B cells from 53BP1/ mice display greatly 
reduced CSR efficiency (Manis et al., 2004). Furthermore, 
similar to observations in NIPBL-deficient patient B cells, the 
pattern of CSR junctions in 53BP1/ mouse B cells is also 
altered, with an increased usage of MH at the S-S junc-
tions (unpublished data), and unusually large insertions at the 
S-S junctions (Reina-San-Martin et al., 2007). It is also of 
note that recruitment of NIPBL to DSBs depends on MDC1 
and RNF168, two DNA damage response factors that have 
previously been implicated in NHEJ during CSR (Oka et al., 
2011). Interestingly, in RNF168-deficient patient B cells, 
Figure 4. 53BP1 foci formation is reduced at an early time point 
in NIPBL-deficient LCLs. LCLs from healthy controls or LCLs deficient in 
NIPBL (P1-P3, P5) were exposed to -IR (1Gy) and harvested, cytospun, 
and fixed at the indicated time points. The cells were then stained with 
anti-53BP1 antibodies and 53BP1 foci were detected using a confocal 
microscope. Image stacks were exported to ImageJ and 53BP1 foci were 
quantified in 40 nuclei per LCL per time point in each experiment. The 
bars represent the relative distribution of 53BP1 foci at indicated time 
points before and after -IR. Two independent experiments were per-
formed. Statistically significant differences are highlighted with stars 
(Mann-Whitney U test).
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were performed according to standard procedures, followed by direct se-
quencing of the coding regions and corresponding exon–intron boundaries 
of PDS5B and KIAA0892, using Big Dye Terminator cycle sequencing kit 
3.1 (Applied Biosystems) and sequenced on an ABI genetic analyzer.
Cell sensitivity to -IR was determined with the MTS or colony 
formation assay. For the MTS assay, cells were seeded at 1.5 × 105 cells/ml 
and exposed to -IR 1–9 Gy, using a 137Cs radiation source (IBL 677; CIS 
Bio International; 15 Gy/min dose rate), 800 ng/ml mitomycin C (Sigma-
Aldrich) for 3 h, or etoposide 300 ng/ml (Sigma-Aldrich) for 36 h. Cells 
were then left to recover during the time required for three calculated pop-
ulation doublings. Cell viability was analyzed using Cell Titer 96 Aqueous 
One Solution MTS Proliferation Assay (Promega) as described by the manu-
facturer. Absorbance values are proportional to the number of viable cells and 
normalized to untreated controls. For colony formation assay, 125–4,000 cells 
were seeded in 6-well plates, incubated for 3–5 h and exposed to various 
doses of -IR as indicated. After 11–17 d recovery, cells were washed in PBS, 
fixed in methanol, dried, and stained using Giemsa stain (Sigma-Aldrich). 
Colonies exceeding 20 cells were counted.
Knockdown of NIPBL expression by siRNA. 2–3 × 105 FBs were 
transfected using DharmaFECT-1 transfection reagent and a pool of four 
siRNAs targeting NIPBL (Thermo Fisher Scientific), according to the man-
ufacturer’s instructions. In brief, cells were incubated with 4 µl transfection 
reagent and 25 nM siRNA in 6-well plates for 48 h, when the cells were 
harvested or -irradiated. For the NHEJ plasmid assay, the siRNA treatment 
was repeated twice but otherwise performed as above. The effect of the 
siNIPBL transfection was detected at the RNA level by real-time PCR or at 
the protein level by Western blotting (see below). Total RNA was extracted 
using the RNeasy Mini kit (QIAGEN). cDNA synthesis was performed 
using 1 µg of total RNA, a NotI-d(T)18 primer and a cDNA synthesis kit 
(GE Healthcare) according to the manufacturer’s protocol. The amplification 
was performed using the Kapa SYBR Fast qPCR Master Mix kit (Kapa 
Biosystems) and the StepOne detection system (Applied Biosystems). For 
analyses of the expression of LIG4, PRKDC, and XRCC5, 500 ng of total 
RNA were used. The housekeeping genes, -actin, GADPH, and HRPT1 
were used for calculation of relative expression levels.
SDS-PAGE and Western blotting. Protein extracts were prepared with 
standard procedures using lysis buffer (10 mM Tris- HCl, pH 8.2, 5 mM 
MgCl2, and 0.1% SDS supplemented with 1 mM PMSF, 10 mM DTT, 1x 
Protease Inhibitor Cocktail (Roche), 1 U DNase, and 10 mg/ml RNase). 
Protein extracts were analyzed by SDS PAGE and Western blotting. For detec-
tion of NIPBL, 3–8% Tris-Acetate gels in 1x Tricine buffer and, for ATM, Chk2 
and XRCC4 and 4–12% Bis-Tris gels in 1x MOPS buffer were used (NuPAGE 
Invitrogen). Proteins were transferred to PVDF Immobilon-P membrane 
(Millipore) in 1x Tris-Glycine buffer supplemented with 20% methanol 
using standard procedures. For NIPBL detection, 0.05% SDS was added and 
blotting was performed for 15 h at 4°C to nitrocellulose membrane (Protean). 
Primary antibodies used were guinea pig anti-NIPBL peptide (Peptide Spe-
cialty Laboratories GmbH; peptide sequences available on request), mouse 
anti–-tubulin (Sigma-Aldrich), mouse anti-phospho-ATM(Ser1981) (NOVUS 
Biological), rabbit anti-Chk2 (Abcam), rabbit anti–phospho-Chk2(Thr68) (Cell 
Signaling Technology), mouse anti-XRCC4 (Abnova), and rabbit anti-histone 
H3 (Abcam).
FACS analyses for determination of cell cycle phase distribution. 
Asynchronously growing or G1-arrested cells were washed twice in ice-cold 
PBS and fixed in 70% ethanol at 4°C, subsequently incubated with RNase A 
40 µg/ml (Sigma-Aldrich) and 20 µg/ml propidium iodide (Sigma-Aldrich) 
at 37°C for 30 min. Analysis was performed with a FACSCalibur system and 
the CellQuest software (BD).
Sequencing of switch recombination junctions. Amplification, cloning, 
and sequencing of the S-S fragments derived from in vivo–switched cells was 
performed using a previously described nested PCR assay (Pan-Hammarström 
recombinase and long range enhancer/promoter interactions 
(Seitan et al., 2011). These types of interactions are known to 
be crucial for induction of germline transcripts encompassing 
the S regions, a requirement for accessibility of the Ig locus 
and thereby for CSR (Stavnezer et al., 2010). However, since 
defective germline transcription has no implication on the 
choice between classical NHEJ and MH-based A-EJ, it would 
be a less likely explanation for the defective NHEJ in NIPBL-
deficient cells. Finally, although the expression level of NHEJ 
genes seems to be normal in NIPBL-deficient cells, it remains 
possible that NIPBL and/or cohesin are important for re-
cruitment of AID, or AID-associated DSB repair factors, to 
the Ig locus. Failure in this recruitment might lead to the shift 
toward usage of the A-EJ pathway (Kracker et al., 2010). This 
possibility needs to be further investigated.
Our study suggests a role for NIPBL in NHEJ during 
CSR where the repetitive, intronic S regions are involved. 
Importantly, a similar function for NIPBL during DSB repair 
in other parts of the genome is plausible, which would have 
more severe effects, as these DSBs can also appear within 
gene-coding regions. Increased resection of DSBs stimulates 
the A-EJ pathway, which has been reported to augment the 
frequency of translocations between chromosomes (Yan et al., 
2007). Thus, an impaired NHEJ may be the underlying reason 
for some of the developmental and neurological defects ob-
served in these patients. It is also important to point out that 
CdLS causing NIPBL mutations are heterozygous loss-of-
function mutations. A more severe NHEJ defect, which could 
lead to a more pronounced immunodeficiency, might be ex-
pected with a complete loss of the NIPBL protein. However, 
as knockout of NIPBL was reported to be incompatible with 
survival (Kawauchi et al., 2009), this question cannot be assessed. 
Further experiments are thus required to completely eluci-
date the functional role of NIPBL/cohesin in NHEJ.
MATERIALS AND METHODS
Patient and control materials. Clinical phenotypes of CdLS patients in-
cluded in this study have been described previously (Pié et al., 2010; Schoumans 
et al., 2007). LCLs were established via Epstein-Barr virus transformation. 
Cell lines (P1-P10) from patients with CdLS were compared with cell lines 
established from unaffected individuals, a patient diagnosed with Roberts 
syndrome, a Cernunnos/ patient and an ataxia telangiectasia patient 
(AT153LA c.8977C>T). LCLs were grown in RPMI 1640 with 10% fetal 
calf serum, glutaMAX, sodium-pyruvate, penicillin (100 U/ml), and strepto-
mycin (0.1 mg/ml). FBs (P7 and P10, one control, and Cernunnos/) were 
cultured in RPMI 1640/HAMS F-10 vol/vol 1:1 or DMEM supplemented 
as medium for LCLs (all from Invitrogen). Genomic DNA samples were pre-
pared from peripheral blood from patients P1-P3, P6, P8, P9, and P10 with 
NIPBL mutations, and four patients with the following ages and mutations 
in SMC1A: S1, 2 yr, c.587G>A; S2, 5 yr, c. 3254A>G; S3, 8 mo, c.2455A>C; 
and S4, 9 yr, c.3568A>G. Peripheral lymphocytes were purified and stored 
using standard methods, from three additional patients with NIPBL muta-
tions (P11, 1 yr, c.1982A>T; P12, 10 yr, 5UTR, c.-321_-320delCCinsA; 
P13, 5 yr, c.771+1G>A). The institutional review board at the Karolinska 
Institutet approved the study.
Mutation analysis of PDS5B and KIAA0892 (MAU2). Genomic DNA 
was isolated from peripheral blood lymphocytes from P4 using Puregene 
blood kit (Gentra Systems Inc.). PCR primer design and PCR amplifications 
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